Easy Bio (XKRX:353810) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Easy Bio Debt-to-Equity?

Easy Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Easy Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Easy Bio's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩63,829 Mil. Easy Bio's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Easy Bio's Debt-to-Equity or its related term are showing as below:

XKRX:353810' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.06 Med: 1.38 Max: 2.31
Current: 1.29

During the past 4 years, the highest Debt-to-Equity Ratio of Easy Bio was 2.31. The lowest was 1.06. And the median was 1.38.

XKRX:353810's Debt-to-Equity is ranked worse than
90.93% of 1070 companies
in the Biotechnology industry
Industry Median: 0.14 vs XKRX:353810: 1.29

Easy Bio Debt-to-Equity Historical Data

The historical data trend for Easy Bio's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easy Bio Debt-to-Equity Chart

Easy Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

1.09

1.19

1.65

1.31

Easy Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial											1.77	1.44	1.66	1.31	-

Competitive Comparison of Easy Bio's Debt-to-Equity

For the Biotechnology subindustry, Easy Bio's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Easy Bio's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Easy Bio's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Easy Bio's Debt-to-Equity falls into.

Easy Bio Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Easy Bio's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(51824.327	+	30453.615)	/	62781.956
	=	1.31

Easy Bio's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	63828.737
	=	0.00

Easy Bio (XKRX:353810) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Easy Bio Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Easy Bio's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Easy Bio (XKRX:353810) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Easy Bio Inc (XKRX:353810) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Gangnam-daero, 4th Floor, Gangnam-gu, Seoul, KOR, 06253

Website

http://www.easybio.co.kr

Easy Bio Inc is a bio-technology company. The company conducts research, manufactures and markets animal feed products in South Korea.

Easy Bio (XKRX:353810) Headlines

No Headlines